These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 32844095)
1. Current protocols and outcomes of ABO-incompatible kidney transplantation. Salvadori M; Tsalouchos A World J Transplant; 2020 Jul; 10(7):191-205. PubMed ID: 32844095 [TBL] [Abstract][Full Text] [Related]
2. [Kidney transplantation from an ABO-incompatible living donor]. Capocasale E; Iaria M; Sassi M; Dalle Valle R; Mazzoni MP; Sianesi M; Franchini M Ann Ital Chir; 2011; 82(4):283-7. PubMed ID: 21834478 [TBL] [Abstract][Full Text] [Related]
4. [Apheresis in ABO-incompatible kidney transplant]. Capocasale E; Iaria M; Sassi M; Mazzoni MP; Franchini M G Ital Nefrol; 2012; 29 Suppl 54():S27-30. PubMed ID: 22388826 [TBL] [Abstract][Full Text] [Related]
5. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients. Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587 [TBL] [Abstract][Full Text] [Related]
10. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Takahashi K; Saito K; Takahara S; Fuchinoue S; Yagisawa T; Aikawa A; Watarai Y; Yoshimura N; Tanabe K; Morozumi K; Shimazu M; Clin Exp Nephrol; 2017 Aug; 21(4):705-713. PubMed ID: 27534951 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation. Sugiyama K; Hyodo Y; Aikawa A Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258 [TBL] [Abstract][Full Text] [Related]
12. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report. Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778 [TBL] [Abstract][Full Text] [Related]
13. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019 [TBL] [Abstract][Full Text] [Related]
14. Pinpoint targeted immunosuppression: anti-CD20/MMF desensitization with anti-CD25 in successful ABO-incompatible kidney transplantation without splenectomy. Saito K; Nakagawa Y; Suwa M; Kumagai N; Tanikawa T; Nishiyama T; Ueno M; Gejyo F; Nishi S; Takahashi K Xenotransplantation; 2006 Mar; 13(2):111-7. PubMed ID: 16623803 [TBL] [Abstract][Full Text] [Related]
15. Japan's experience with living-donor kidney transplantation across ABO barriers. Ichimaru N; Takahara S Nat Clin Pract Nephrol; 2008 Dec; 4(12):682-92. PubMed ID: 18941430 [TBL] [Abstract][Full Text] [Related]
16. Kidney paired exchange and desensitization: Strategies to transplant the difficult to match kidney patients with living donors. Pham TA; Lee JI; Melcher ML Transplant Rev (Orlando); 2017 Jan; 31(1):29-34. PubMed ID: 28284304 [TBL] [Abstract][Full Text] [Related]
17. Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature. Thukral S; Shinde N; Mukherjee K; Ray DS Am J Case Rep; 2019 Mar; 20():285-289. PubMed ID: 30828083 [TBL] [Abstract][Full Text] [Related]